Neurologie [Neurology : what's new in 2021]

Détails

Ressource 1Télécharger: RMS_764-5_51.pdf (128.24 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_A713627E7914
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Neurologie [Neurology : what's new in 2021]
Périodique
Revue medicale suisse
Auteur⸱e⸱s
Vicino A., Allali G., Bally J., Castro Jimenez M., Chiabotti Salvioni P., Hirt L., Hottinger A., Michel P., Novy J., Pot Kreis C., Rossetti A., Rouaud O., Ryvlin P., Théaudin M., Du Pasquier R.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
19/01/2022
Peer-reviewed
Oui
Volume
18
Numéro
764-5
Pages
51-55
Langue
français
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
In 2021, we assisted to the publication of new diagnostic criteria, classifications, and guidelines (CIDP, brain tumors, auto-immune encephalitis). Several studies helped to define the pharmacological management of focal and generalized epileptic seizures and epilepsy in pregnant women. The availability of biomarkers and the approval of immunotherapies are modifying the landscape of dementia management. Endovascular interventions without previous thrombolysis seems to be effective in anterior circulation acute ischemic stroke (AIS) and severe posterior circulation AIS. Neurologic complications of Sars-CoV-2 infection were further studied, as well as the efficacy of vaccines in immunosuppressed patients. New molecules and techniques show promising results for the treatment of migraine and cluster headache.
Mots-clé
Brain Ischemia, COVID-19, Endovascular Procedures, Epilepsy, Female, Humans, Neurology, Pregnancy, SARS-CoV-2, Stroke/diagnosis, Stroke/therapy
Pubmed
Création de la notice
31/01/2022 11:57
Dernière modification de la notice
02/10/2023 5:58
Données d'usage